These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 766041)

  • 81. Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
    Corona GL; Pinelli P; Zerbi F; Fenoglio L; Santagostino G; Frattini P; Cucchi ML
    Pharmakopsychiatr Neuropsychopharmakol; 1980 May; 13(3):102-10. PubMed ID: 7393996
    [TBL] [Abstract][Full Text] [Related]  

  • 82. EEG sleep and tricyclic blood levels: acute and chronic administration in depression.
    Kupfer DJ; Hanin I; Coble PA; Spiker DG; Sorisio D; Grau TG
    J Clin Psychopharmacol; 1982 Feb; 2(1):8-13. PubMed ID: 7068946
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Treatment of cognitive impairment after poststroke depression : a double-blind treatment trial.
    Kimura M; Robinson RG; Kosier JT
    Stroke; 2000 Jul; 31(7):1482-6. PubMed ID: 10884441
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Monitoring of tricyclic antidepressant therapy.
    Dawling S
    Clin Biochem; 1982 Feb; 15(1):56-61. PubMed ID: 7067078
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Nortriptyline in depressed patients with high plasma levels. II.
    Braithwaite R; Montgomery S; Dawling S
    Clin Pharmacol Ther; 1978 Mar; 23(3):303-8. PubMed ID: 627136
    [No Abstract]   [Full Text] [Related]  

  • 86. Self-inhibiting action of nortriptyline's anti-immobility effect at high plasma and brain levels in mice.
    Reis de Oliveria I; Diquet B; Van der Meersch V; Dardennes R; Gonidec J; do Prado-Lima PA
    Psychopharmacology (Berl); 1990; 102(4):553-6. PubMed ID: 2096414
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.
    Nordin C; Bertilsson L
    Clin Pharmacokinet; 1995 Jan; 28(1):26-40. PubMed ID: 7712660
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years.
    Reynolds CF; Frank E; Perel JM; Imber SD; Cornes C; Miller MD; Mazumdar S; Houck PR; Dew MA; Stack JA; Pollock BG; Kupfer DJ
    JAMA; 1999 Jan; 281(1):39-45. PubMed ID: 9892449
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation.
    Prochazka AV; Kick S; Steinbrunn C; Miyoshi T; Fryer GE
    Arch Intern Med; 2004 Nov; 164(20):2229-33. PubMed ID: 15534159
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.
    Mulsant BH; Sweet RA; Rosen J; Pollock BG; Zubenko GS; Flynn T; Begley AE; Mazumdar S; Reynolds CF
    J Clin Psychiatry; 2001 Aug; 62(8):597-604. PubMed ID: 11561930
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression.
    Akhondzadeh S; Faraji H; Sadeghi M; Afkham K; Fakhrzadeh H; Kamalipour A
    J Clin Pharm Ther; 2003 Oct; 28(5):379-84. PubMed ID: 14632962
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Double blind clinical study of mianserin and nortriptyline (author's transl)].
    Hoc J
    Acta Psychiatr Belg; 1978; 78(5):833-40. PubMed ID: 375687
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The Usefulness of In Vitro Percutaneous Absorption Experiments Applying the Infinite Dose Technique to Predict In Vivo Plasma Levels: Comparison of Model-Predicted and Observed Plasma Concentrations of Nortriptyline in Rats.
    Usach I; Di Marco S; Díez O; Alós M; Peris JE
    Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890351
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2.
    Sekine M; Arakawa R; Ito H; Okumura M; Sasaki T; Takahashi H; Takano H; Okubo Y; Halldin C; Suhara T
    Psychopharmacology (Berl); 2010 Jun; 210(3):331-6. PubMed ID: 20309528
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Therapeutic drug monitoring of nortriptyline in smoking cessation: a multistudy analysis.
    Mooney ME; Reus VI; Gorecki J; Hall SM; Humfleet GL; Muñoz RF; Delucchi K
    Clin Pharmacol Ther; 2008 Mar; 83(3):436-42. PubMed ID: 17687275
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review.
    Adli M; Baethge C; Heinz A; Langlitz N; Bauer M
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):387-400. PubMed ID: 15868067
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Landmark publications in Psychopharmacology: the first 40 years.
    Miczek KA
    Psychopharmacology (Berl); 2001 Feb; 153(4):399-401. PubMed ID: 11243486
    [No Abstract]   [Full Text] [Related]  

  • 98. Population pharmacokinetics and pharmacodynamics: potential use for gathering dose-concentration-response.
    Jerling M
    Eur J Drug Metab Pharmacokinet; 1996; 21(2):113-21. PubMed ID: 8839684
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pharmacokinetic optimisation of tricyclic antidepressant therapy.
    Furlanut M; Benetello P; Spina E
    Clin Pharmacokinet; 1993 Apr; 24(4):301-18. PubMed ID: 8491058
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Pharmacokinetic and pharmacodynamic data and models in clinical trials.
    Steimer JL; Ebelin ME; Van Bree J
    Eur J Drug Metab Pharmacokinet; 1993; 18(1):61-76. PubMed ID: 8335040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.